Table 1.
Presenting features of patients on AML97 and AML902.
| AML97 (n=92) | AML02 (n=216) | p value | |
|---|---|---|---|
|
| |||
| Age (years) | 9.0 (0.0 - 20.0) | 8.1 (0.0 - 21.0) | |
| Sex | |||
| Male | 49% (45) | 56% (121) | 0.454 |
| Female | 51% (47) | 44% (95) | |
| WBC Count | |||
| < 50,000 | 76% (70) | 74% (160) | 0.776 |
| ≥ 50,000 | 24% (22) | 26% (56) | |
| FAB | |||
| M0 | 2% (2) | 1% (2) | 0.586 |
| M1 | 17% (16) | 11% (24) | 0.141 |
| M2 | 24% (22) | 18% (38) | 0.211 |
| M4 | 21% (19) | 25% (55) | 0.387 |
| M5 | 17% (16) | 25% (54) | 0.181 |
| M6 | 0% (0) | 1% (2) | 0.999 |
| M7 | 14% (13) | 12% (25) | 0.571 |
| Unknown | 4% (4) | 7% (16) | 0.45 |
| Initial Risk | |||
| Low | 24% (22) | 32% (68) | 0.218 |
| Standard | 42% (39) | 36% (77) | 0.304 |
| High | 34% (31) | 33% (71) | 0.937 |